VIM and breast carcinoma: Immunoblot analyses revealed that BRC-31 breast cancer cells retained expression of EGFR, N-cadherin, fibronectin (FN) and vimentin at higher levels relative to BRC-32, 36 and 196 breast cancer cells (Fig. 1f).